False Liver Metastasis by Positron Emission Tomography/Computed Tomography Scan after Chemoradiotherapy for Esophageal Cancer-Potential Overstaged Pitfalls of Treatment
In patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) can reveal the presence of interval metastases, such as liver metastases, in approximately 10% of...
Saved in:
Published in | Cancers Vol. 16; no. 5; p. 948 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
26.02.2024
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) can reveal the presence of interval metastases, such as liver metastases, in approximately 10% of cases. Nevertheless, it is not uncommon in clinical practice to observe focal FDG uptake in the liver that is not associated with liver metastases but rather with radiation-induced liver injury (RILI), which can result in the overstaging of the disease. Liver radiation damage is also a concern during distal esophageal cancer radiotherapy due to its proximity to the left liver lobe, typically included in the radiation field. Post-CRT, if FDG activity appears in the left or caudate liver lobes, a thorough investigation is needed to confirm or rule out distant metastases. The increased FDG uptake in liver lobes post-CRT often presents a diagnostic dilemma. Distinguishing between radiation-induced liver disease and metastasis is vital for appropriate patient management, necessitating a combination of imaging techniques and an understanding of the factors influencing the radiation response. Diagnosis involves identifying new foci of hepatic FDG avidity on PET/CT scans. Geographic regions of hypoattenuation on CT and well-demarcated regions with specific enhancement patterns on contrast-enhanced CT scans and MRI are characteristic of radiation-induced liver disease (RILD). Lack of mass effect on all three modalities (CT, MRI, PET) indicates RILD. Resolution of abnormalities on subsequent examinations also helps in diagnosing RILD. Moreover, it can also help to rule out occult metastases, thereby excluding those patients from further surgery who will not benefit from esophagectomy with curative intent. |
---|---|
AbstractList | In patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) can reveal the presence of interval metastases, such as liver metastases, in approximately 10% of cases. Nevertheless, it is not uncommon in clinical practice to observe focal FDG uptake in the liver that is not associated with liver metastases but rather with radiation-induced liver injury (RILI), which can result in the overstaging of the disease. Liver radiation damage is also a concern during distal esophageal cancer radiotherapy due to its proximity to the left liver lobe, typically included in the radiation field. Post-CRT, if FDG activity appears in the left or caudate liver lobes, a thorough investigation is needed to confirm or rule out distant metastases. The increased FDG uptake in liver lobes post-CRT often presents a diagnostic dilemma. Distinguishing between radiation-induced liver disease and metastasis is vital for appropriate patient management, necessitating a combination of imaging techniques and an understanding of the factors influencing the radiation response. Diagnosis involves identifying new foci of hepatic FDG avidity on PET/CT scans. Geographic regions of hypoattenuation on CT and well-demarcated regions with specific enhancement patterns on contrast-enhanced CT scans and MRI are characteristic of radiation-induced liver disease (RILD). Lack of mass effect on all three modalities (CT, MRI, PET) indicates RILD. Resolution of abnormalities on subsequent examinations also helps in diagnosing RILD. Moreover, it can also help to rule out occult metastases, thereby excluding those patients from further surgery who will not benefit from esophagectomy with curative intent. FDG PET-CT scans are critical in detecting metastases during neoadjuvant chemoradiotherapy for esophageal cancer, particularly for potential liver involvement. The liver’s proximity to the radiation field in distal esophageal cancer therapies raises the risk of radiation-induced liver damage. Therefore, greater FDG absorption in the liver does not always imply metastases; it could also signal radiation-induced damage, which is a concern for distal esophageal carcinoma therapies in the left hepatic lobe, potentially leading to overstaging. Accordingly, thorough monitoring of FDG activity in the liver is required to reliably distinguish between radiation effects and genuine distant metastases. If FDG activity is seen in the left or caudate liver lobes following CRT, additional diagnostic procedures are demanded to confirm or rule out distant metastases. Surgery, usually scheduled 6–8 weeks after CRT, should be followed by an FDG PET-CT scan to look for new interval metastases, as their existence may prohibit surgical intervention. In patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) can reveal the presence of interval metastases, such as liver metastases, in approximately 10% of cases. Nevertheless, it is not uncommon in clinical practice to observe focal FDG uptake in the liver that is not associated with liver metastases but rather with radiation-induced liver injury (RILI), which can result in the overstaging of the disease. Liver radiation damage is also a concern during distal esophageal cancer radiotherapy due to its proximity to the left liver lobe, typically included in the radiation field. Post-CRT, if FDG activity appears in the left or caudate liver lobes, a thorough investigation is needed to confirm or rule out distant metastases. The increased FDG uptake in liver lobes post-CRT often presents a diagnostic dilemma. Distinguishing between radiation-induced liver disease and metastasis is vital for appropriate patient management, necessitating a combination of imaging techniques and an understanding of the factors influencing the radiation response. Diagnosis involves identifying new foci of hepatic FDG avidity on PET/CT scans. Geographic regions of hypoattenuation on CT and well-demarcated regions with specific enhancement patterns on contrast-enhanced CT scans and MRI are characteristic of radiation-induced liver disease (RILD). Lack of mass effect on all three modalities (CT, MRI, PET) indicates RILD. Resolution of abnormalities on subsequent examinations also helps in diagnosing RILD. Moreover, it can also help to rule out occult metastases, thereby excluding those patients from further surgery who will not benefit from esophagectomy with curative intent. FDG PET-CT scans are critical in detecting metastases during neoadjuvant chemoradiotherapy for esophageal cancer, particularly for potential liver involvement. The liver’s proximity to the radiation field in distal esophageal cancer therapies raises the risk of radiation-induced liver damage. Therefore, greater FDG absorption in the liver does not always imply metastases; it could also signal radiation-induced damage, which is a concern for distal esophageal carcinoma therapies in the left hepatic lobe, potentially leading to overstaging. Accordingly, thorough monitoring of FDG activity in the liver is required to reliably distinguish between radiation effects and genuine distant metastases. If FDG activity is seen in the left or caudate liver lobes following CRT, additional diagnostic procedures are demanded to confirm or rule out distant metastases. Surgery, usually scheduled 6–8 weeks after CRT, should be followed by an FDG PET-CT scan to look for new interval metastases, as their existence may prohibit surgical intervention. Simple SummaryFDG PET-CT scans are critical in detecting metastases during neoadjuvant chemoradiotherapy for esophageal cancer, particularly for potential liver involvement. The liver’s proximity to the radiation field in distal esophageal cancer therapies raises the risk of radiation-induced liver damage. Therefore, greater FDG absorption in the liver does not always imply metastases; it could also signal radiation-induced damage, which is a concern for distal esophageal carcinoma therapies in the left hepatic lobe, potentially leading to overstaging. Accordingly, thorough monitoring of FDG activity in the liver is required to reliably distinguish between radiation effects and genuine distant metastases. If FDG activity is seen in the left or caudate liver lobes following CRT, additional diagnostic procedures are demanded to confirm or rule out distant metastases. Surgery, usually scheduled 6–8 weeks after CRT, should be followed by an FDG PET-CT scan to look for new interval metastases, as their existence may prohibit surgical intervention.AbstractIn patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) can reveal the presence of interval metastases, such as liver metastases, in approximately 10% of cases. Nevertheless, it is not uncommon in clinical practice to observe focal FDG uptake in the liver that is not associated with liver metastases but rather with radiation-induced liver injury (RILI), which can result in the overstaging of the disease. Liver radiation damage is also a concern during distal esophageal cancer radiotherapy due to its proximity to the left liver lobe, typically included in the radiation field. Post-CRT, if FDG activity appears in the left or caudate liver lobes, a thorough investigation is needed to confirm or rule out distant metastases. The increased FDG uptake in liver lobes post-CRT often presents a diagnostic dilemma. Distinguishing between radiation-induced liver disease and metastasis is vital for appropriate patient management, necessitating a combination of imaging techniques and an understanding of the factors influencing the radiation response. Diagnosis involves identifying new foci of hepatic FDG avidity on PET/CT scans. Geographic regions of hypoattenuation on CT and well-demarcated regions with specific enhancement patterns on contrast-enhanced CT scans and MRI are characteristic of radiation-induced liver disease (RILD). Lack of mass effect on all three modalities (CT, MRI, PET) indicates RILD. Resolution of abnormalities on subsequent examinations also helps in diagnosing RILD. Moreover, it can also help to rule out occult metastases, thereby excluding those patients from further surgery who will not benefit from esophagectomy with curative intent. |
Audience | Academic |
Author | Lai, Yi-Ling Shai, Sen-Ei Hsieh, Chi-Wei Chang, Chen-I |
AuthorAffiliation | 5 School of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; i54091149@gs.ncku.edu.tw 4 School of Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan; jenny28950.md07@nycu.edu.tw 2 Department of Applied Chemistry, National Chi Nan University, Nantou 545301, Taiwan 1 Department of Thoracic Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan; linglai@vghtc.gov.tw 3 Institute of Clinical Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan |
AuthorAffiliation_xml | – name: 1 Department of Thoracic Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan; linglai@vghtc.gov.tw – name: 5 School of Medicine, National Cheng Kung University, Tainan 701401, Taiwan; i54091149@gs.ncku.edu.tw – name: 2 Department of Applied Chemistry, National Chi Nan University, Nantou 545301, Taiwan – name: 3 Institute of Clinical Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan – name: 4 School of Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan; jenny28950.md07@nycu.edu.tw |
Author_xml | – sequence: 1 givenname: Sen-Ei surname: Shai fullname: Shai, Sen-Ei organization: Institute of Clinical Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan – sequence: 2 givenname: Yi-Ling surname: Lai fullname: Lai, Yi-Ling organization: Department of Thoracic Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan – sequence: 3 givenname: Chen-I surname: Chang fullname: Chang, Chen-I organization: School of Medicine, National Yang-Ming Chiao-Tung University, Taipei 112304, Taiwan – sequence: 4 givenname: Chi-Wei surname: Hsieh fullname: Hsieh, Chi-Wei organization: School of Medicine, National Cheng Kung University, Tainan 701401, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38473310$$D View this record in MEDLINE/PubMed |
BookMark | eNptklFv2yAQx62p09p1fd7bhLSXvaQ1YIN5mqoo3SplaqTlHWE4O0S2ycCplG-0j7lL03VJNWMJOP734-6499nZEAbIso80v-Zc5TfWDBZioiIvc1VUb7ILlks2EUIVZ0fr8-wqpXWOH-dUCvkuO-dVIXGTX2S_70yXgMz9I0TyA0aT8PeJ1DuyCMmPMQxk1vuUPC6WoQ9tNJvV7mYa-s12BHdkIz8xIGKaEUnTFfQhGufDuAI83ZEmRDJLYbMyLZiOTJ9inyzCCMPo0fCAAeDdLSIXfmxM1yUSGrKMYMYeNR-yt80-1Kvn-TJb3s2W0--T-cO3--ntfGKxCONESaeco5w5Z2hdiQKMw0wLYZVVFARTqjaW29JyaZ0QPK8rCUJIRqWsgV9m9wesC2atN9H3Ju50MF4_GUJstYmjtx1ogKqwIHOuWF1w4LVjTcGqksqmyJkwyPp6YG22dQ_OYhbRdCfQ05PBr3QbHjXNFaeMMyR8eSbE8GsLadT4FBa6zgwQtkkzVQpRFVyUKP38SroO2zhgqfaqssCnL-k_VWswAz80AS-2e6i-lVgtzqiqUHX9HxUOB7232ISNR_uJw83BwcaQUoTmJUma632v6le9ih6fjmvzov_bmfwPg0_qXQ |
Cites_doi | 10.1148/radiol.2422051113 10.1016/j.ijrobp.2009.12.054 10.1097/MEG.0b013e3282f5f5d5 10.1007/s00330-016-4227-4 10.1371/journal.pone.0133690 10.1016/j.crad.2010.12.004 10.1097/JTO.0b013e3181bbf208 10.1097/RLU.0b013e3182443e14 10.1016/j.surg.2009.04.024 10.1245/s10434-016-5754-6 10.1007/s00270-014-0872-7 10.1016/S1470-2045(15)00040-6 10.1016/S1470-2045(11)70142-5 10.1016/j.radonc.2012.09.024 10.1016/j.crad.2009.03.005 10.1111/j.1442-2050.2007.00732.x 10.1200/JCO.2007.14.5631 10.2214/ajr.184.4.01841091 10.1016/j.ejrad.2009.03.051 10.2214/ajr.157.1.1904679 10.1016/j.crad.2014.08.010 10.1016/j.semradonc.2005.04.005 10.1016/j.jnci.2015.08.001 10.1634/theoncologist.6-2-162 10.1097/01.rlu.0000222675.10765.14 10.1016/j.jtcvs.2004.12.042 10.2214/ajr.135.3.445 10.1148/rg.336125105 10.1038/emm.2017.85 10.1148/radiol.2382041977 10.1097/MD.0000000000023210 10.1016/S0360-3016(02)02846-8 10.1007/s00066-017-1217-7 10.2214/AJR.07.2083 10.1097/01.sla.0000208430.07050.61 10.1016/j.ejso.2011.06.002 10.1148/rg.344140082 10.1016/S1072-7515(00)00238-6 10.1053/j.semnuclmed.2010.02.002 10.2214/ajr.165.1.7785638 10.1016/j.bpg.2011.02.005 10.1007/s00259-018-4011-6 10.5603/NMR.2013.0039 10.1102/1470-7330.2007.0027 10.1016/0360-3016(94)00418-K 10.1148/radiographics.15.5.7501852 10.1080/00015458.2016.1248120 10.1097/00004728-198703000-00013 10.1002/cncr.22397 10.2214/AJR.05.0941 10.1056/NEJMra035010 10.1093/annonc/mdf081 10.1016/S0140-6736(12)60643-6 10.1186/s41747-021-00250-0 10.1186/s13014-019-1396-8 10.1097/RLU.0000000000000517 10.1016/j.semradonc.2011.05.003 10.1200/JCO.2010.30.7702 10.1002/hep.510260117 10.1200/JCO.2004.07.122 10.1148/rg.276065742 10.1158/1078-0432.CCR-06-2459 10.1200/JCO.2001.19.12.3058 10.1007/s00330-006-0404-1 10.1097/RCT.0000000000000406 10.1007/s00261-014-0125-x 10.1016/j.ejca.2012.12.027 10.1186/s13256-020-02391-z |
ContentType | Journal Article |
Copyright | COPYRIGHT 2024 MDPI AG 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 by the authors. 2024 |
Copyright_xml | – notice: COPYRIGHT 2024 MDPI AG – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 by the authors. 2024 |
DBID | NPM AAYXX CITATION 3V. 7T5 7TO 7XB 8FE 8FH 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ GUQSH H94 HCIFZ LK8 M2O M7P MBDVC PIMPY PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.3390/cancers16050948 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Oncogenes and Growth Factors Abstracts ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Biological Sciences ProQuest research library Biological Science Database Research Library (Corporate) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2072-6694 |
ExternalDocumentID | oai_doaj_org_article_ee84ce70392b43e3bd2f428517f4026a A786432198 10_3390_cancers16050948 38473310 |
Genre | Journal Article Review |
GeographicLocations | Taiwan |
GeographicLocations_xml | – name: Taiwan |
GrantInformation_xml | – fundername: Taichung Veterans General Hospital and National Yang-Ming University grantid: TCVGH-YM1110105 – fundername: Taichung Veterans General Hospital and Taichung Veterans General Hospital Chiayi Branch grantid: TCVGH-VHCY1128602 – fundername: Yen Tjing Ling Medical Foundation grantid: CI-112-9 – fundername: Taichung Veterans General Hospital; Taichung Veterans General Hospital Chiayi Branch grantid: TCVGH-VHCY1128602 – fundername: Taichung Veterans General Hospital; National Yang-Ming University, Taichung grantid: TCVGH-YM1110105 |
GroupedDBID | --- 3V. 53G 5VS 8FE 8FH 8G5 AADQD AAFWJ ABDBF ABUWG ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU DIK DWQXO E3Z EBD ESX GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR ITC KQ8 LK8 M2O M48 M7P MODMG M~E NPM OK1 P6G PGMZT PIMPY PQQKQ PROAC RIG RPM TUS AAYXX CITATION ABMYL 7T5 7TO 7XB 8FK H94 MBDVC PQEST PQUKI Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c509t-97d9dd132dda1b864ead33146c9c91e6299bac3c5c37cd6630b87e6672177be3 |
IEDL.DBID | RPM |
ISSN | 2072-6694 |
IngestDate | Thu Jul 04 20:52:23 EDT 2024 Tue Sep 17 21:29:09 EDT 2024 Sat Aug 17 03:04:38 EDT 2024 Fri Sep 13 08:57:57 EDT 2024 Wed Mar 20 18:13:05 EDT 2024 Tue Mar 19 05:07:18 EDT 2024 Fri Aug 23 01:16:46 EDT 2024 Sat Sep 28 08:17:59 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | F-18-fluorodeoxyglucose (18F-FDG) radiation-induced liver injury (RILI) neoadjuvant chemoradiotherapy (nCRT) positron emission tomography–computed tomography (PET-CT) false liver metastasis radiation-induced liver disease (RILD) |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c509t-97d9dd132dda1b864ead33146c9c91e6299bac3c5c37cd6630b87e6672177be3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10931232/ |
PMID | 38473310 |
PQID | 2955431751 |
PQPubID | 2032421 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ee84ce70392b43e3bd2f428517f4026a pubmedcentral_primary_oai_pubmedcentral_nih_gov_10931232 proquest_miscellaneous_2956684365 proquest_journals_2955431751 gale_infotracmisc_A786432198 gale_infotracacademiconefile_A786432198 crossref_primary_10_3390_cancers16050948 pubmed_primary_38473310 |
PublicationCentury | 2000 |
PublicationDate | 20240226 |
PublicationDateYYYYMMDD | 2024-02-26 |
PublicationDate_xml | – month: 2 year: 2024 text: 20240226 day: 26 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Cancers |
PublicationTitleAlternate | Cancers (Basel) |
PublicationYear | 2024 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Jacene (ref_33) 2006; 31 Jeffrey (ref_59) 1980; 135 Vernuccio (ref_63) 2021; 5 Seidensticker (ref_66) 2015; 38 Iyer (ref_13) 2007; 7 Liu (ref_24) 2010; 40 Kwek (ref_61) 2006; 187 Flamen (ref_39) 2002; 13 Smithers (ref_7) 2008; 21 Findlay (ref_42) 2016; 26 Henning (ref_70) 2007; 17 Dawson (ref_51) 2005; 15 Viswanathan (ref_64) 2014; 34 Lawrence (ref_18) 1995; 31 Yamasaki (ref_52) 1995; 165 Nakahara (ref_5) 2008; 20 Daly (ref_4) 2000; 190 Weber (ref_41) 2001; 19 Kim (ref_17) 2017; 49 Reed (ref_15) 1966; 48 Shai (ref_48) 2020; 14 Heeren (ref_35) 2004; 45 Som (ref_23) 1980; 21 Lee (ref_55) 2011; 25 Unger (ref_60) 1987; 11 Wong (ref_45) 2012; 37 ref_72 Jelvehgaran (ref_65) 2019; 14 King (ref_57) 2001; 6 Dawson (ref_50) 2002; 53 Chowdhury (ref_32) 2009; 64 Hillner (ref_27) 2008; 26 Culverwell (ref_31) 2011; 66 Gabriel (ref_21) 2017; 24 Sempoux (ref_71) 1997; 26 Metser (ref_29) 2007; 189 Guha (ref_58) 2011; 21 Munden (ref_53) 2005; 184 Monjazeb (ref_6) 2010; 28 Bruzzi (ref_9) 2007; 27 Beatty (ref_30) 2009; 146 Cerfolio (ref_40) 2005; 129 Ulaner (ref_37) 2013; 33 Benson (ref_16) 2016; 28 Steinert (ref_25) 2006; 238 Levine (ref_43) 2006; 243 Yankelevitz (ref_69) 1991; 157 Li (ref_73) 2020; 99 Enzinger (ref_54) 2003; 349 Blom (ref_8) 2011; 37 Poeppel (ref_28) 2009; 70 Umezawa (ref_67) 2014; 69 Pennathur (ref_1) 2013; 381 Sjoquist (ref_2) 2011; 12 Grant (ref_22) 2014; 39 Fajardo (ref_49) 1980; 104 Shapiro (ref_3) 2015; 16 Ferlay (ref_34) 2013; 49 Itai (ref_62) 1995; 15 Luk (ref_47) 2013; 16 Chou (ref_20) 2007; 13 DeLappe (ref_44) 2009; 4 Blodgett (ref_26) 2007; 242 Wieder (ref_56) 2004; 22 Rabe (ref_12) 2016; 40 Goense (ref_11) 2018; 45 Voncken (ref_14) 2018; 194 Bruzzi (ref_38) 2007; 109 Machann (ref_68) 2011; 79 Demey (ref_46) 2017; 117 Ogata (ref_19) 1963; 10 Stiekema (ref_10) 2014; 39 Nijkamp (ref_36) 2013; 106 |
References_xml | – volume: 242 start-page: 360 year: 2007 ident: ref_26 article-title: PET/CT: Form and function publication-title: Radiology doi: 10.1148/radiol.2422051113 contributor: fullname: Blodgett – volume: 79 start-page: 1117 year: 2011 ident: ref_68 article-title: Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin’s disease publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2009.12.054 contributor: fullname: Machann – volume: 20 start-page: 1040 year: 2008 ident: ref_5 article-title: Dose-related fluorodeoxyglucose uptake in acute radiation-induced hepatitis publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/MEG.0b013e3282f5f5d5 contributor: fullname: Nakahara – volume: 26 start-page: 3519 year: 2016 ident: ref_42 article-title: Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: Identifying interval metastases and predicting incurable disease at surgery publication-title: Eur. Radiol. doi: 10.1007/s00330-016-4227-4 contributor: fullname: Findlay – ident: ref_72 doi: 10.1371/journal.pone.0133690 – volume: 66 start-page: 366 year: 2011 ident: ref_31 article-title: False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging publication-title: Clin. Radiol. doi: 10.1016/j.crad.2010.12.004 contributor: fullname: Culverwell – volume: 4 start-page: 1442 year: 2009 ident: ref_44 article-title: Hepatic radiation injury mimicking a metastasis on positron-emission tomography/computed tomography in a patient with esophageal carcinoma publication-title: J. Thorac. Oncol. doi: 10.1097/JTO.0b013e3181bbf208 contributor: fullname: DeLappe – volume: 37 start-page: 709 year: 2012 ident: ref_45 article-title: Hepatic radiation injury in distal esophageal carcinoma: A case report publication-title: Clin. Nucl. Med. doi: 10.1097/RLU.0b013e3182443e14 contributor: fullname: Wong – volume: 146 start-page: 274 year: 2009 ident: ref_30 article-title: Incidental PET/CT findings in the cancer patient: How should they be managed? publication-title: Surgery doi: 10.1016/j.surg.2009.04.024 contributor: fullname: Beatty – volume: 24 start-page: 1739 year: 2017 ident: ref_21 article-title: Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer publication-title: Ann. Surg. Oncol. doi: 10.1245/s10434-016-5754-6 contributor: fullname: Gabriel – volume: 38 start-page: 213 year: 2015 ident: ref_66 article-title: Radiation-induced liver damage: Correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study publication-title: Cardiovasc. Intervent Radiol. doi: 10.1007/s00270-014-0872-7 contributor: fullname: Seidensticker – volume: 16 start-page: 1090 year: 2015 ident: ref_3 article-title: Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(15)00040-6 contributor: fullname: Shapiro – volume: 104 start-page: 584 year: 1980 ident: ref_49 article-title: Pathogenesis of veno-occlusive liver disease after radiation publication-title: Arch. Pathol. Lab. Med. contributor: fullname: Fajardo – volume: 12 start-page: 681 year: 2011 ident: ref_2 article-title: Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(11)70142-5 contributor: fullname: Sjoquist – volume: 106 start-page: 118 year: 2013 ident: ref_36 article-title: Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2012.09.024 contributor: fullname: Nijkamp – volume: 64 start-page: 675 year: 2009 ident: ref_32 article-title: Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: Prevalence and disease pattern publication-title: Clin. Radiol. doi: 10.1016/j.crad.2009.03.005 contributor: fullname: Chowdhury – volume: 21 start-page: 151 year: 2008 ident: ref_7 article-title: Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus publication-title: Dis. Esophagus doi: 10.1111/j.1442-2050.2007.00732.x contributor: fullname: Smithers – volume: 26 start-page: 2155 year: 2008 ident: ref_27 article-title: Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: Initial results from the National Oncologic PET Registry publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2007.14.5631 contributor: fullname: Hillner – volume: 184 start-page: 1091 year: 2005 ident: ref_53 article-title: Radiation injury to the liver after intensity-modulated radiation therapy in patients with mesothelioma: An unusual CT appearance publication-title: Am. J. Roentgenol. doi: 10.2214/ajr.184.4.01841091 contributor: fullname: Munden – volume: 70 start-page: 382 year: 2009 ident: ref_28 article-title: PET/CT for the staging and follow-up of patients with malignancies publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2009.03.051 contributor: fullname: Poeppel – volume: 157 start-page: 87 year: 1991 ident: ref_69 article-title: Effect of radiation therapy on thoracic and lumbar bone marrow: Evaluation with MR imaging publication-title: Am. J. Roentgenol. doi: 10.2214/ajr.157.1.1904679 contributor: fullname: Yankelevitz – volume: 69 start-page: 1273 year: 2014 ident: ref_67 article-title: MRI findings of radiation-induced myocardial damage in patients with oesophageal cancer publication-title: Clin. Radiol. doi: 10.1016/j.crad.2014.08.010 contributor: fullname: Umezawa – volume: 15 start-page: 279 year: 2005 ident: ref_51 article-title: Partial volume tolerance of the liver to radiation publication-title: Semin. Radiat. Oncol. doi: 10.1016/j.semradonc.2005.04.005 contributor: fullname: Dawson – volume: 28 start-page: 7 year: 2016 ident: ref_16 article-title: Radiation induced liver disease: A clinical update publication-title: J. Egypt. Natl. Canc Inst. doi: 10.1016/j.jnci.2015.08.001 contributor: fullname: Benson – volume: 6 start-page: 162 year: 2001 ident: ref_57 article-title: Hepatotoxicity of chemotherapy publication-title: Oncologist doi: 10.1634/theoncologist.6-2-162 contributor: fullname: King – volume: 31 start-page: 379 year: 2006 ident: ref_33 article-title: Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT publication-title: Clin. Nucl. Med. doi: 10.1097/01.rlu.0000222675.10765.14 contributor: fullname: Jacene – volume: 129 start-page: 1232 year: 2005 ident: ref_40 article-title: The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy publication-title: J. Thorac. Cardiovasc. Surg. doi: 10.1016/j.jtcvs.2004.12.042 contributor: fullname: Cerfolio – volume: 135 start-page: 445 year: 1980 ident: ref_59 article-title: CT of radiation-induced hepatic injury publication-title: Am. J. Roentgenol. doi: 10.2214/ajr.135.3.445 contributor: fullname: Jeffrey – volume: 33 start-page: 1817 year: 2013 ident: ref_37 article-title: Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT publication-title: Radiographics doi: 10.1148/rg.336125105 contributor: fullname: Ulaner – volume: 49 start-page: e359 year: 2017 ident: ref_17 article-title: Radiation-induced liver disease: Current understanding and future perspectives publication-title: Exp. Mol. Med. doi: 10.1038/emm.2017.85 contributor: fullname: Kim – volume: 238 start-page: 405 year: 2006 ident: ref_25 article-title: Integrated PET/CT: Current applications and future directions publication-title: Radiology doi: 10.1148/radiol.2382041977 contributor: fullname: Steinert – volume: 99 start-page: e23210 year: 2020 ident: ref_73 article-title: Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary publication-title: Medicine doi: 10.1097/MD.0000000000023210 contributor: fullname: Li – volume: 53 start-page: 810 year: 2002 ident: ref_50 article-title: Analysis of radiation-induced liver disease using the Lyman NTCP model publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/S0360-3016(02)02846-8 contributor: fullname: Dawson – volume: 194 start-page: 156 year: 2018 ident: ref_14 article-title: Radiation-induced liver injury mimicking liver metastases on FDG-PET-CT after chemoradiotherapy for esophageal cancer: A retrospective study and literature review publication-title: Strahlenther. Onkol. doi: 10.1007/s00066-017-1217-7 contributor: fullname: Voncken – volume: 189 start-page: 1203 year: 2007 ident: ref_29 article-title: Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: Characterization and incidence publication-title: Am. J. Roentgenol. doi: 10.2214/AJR.07.2083 contributor: fullname: Metser – volume: 45 start-page: 980 year: 2004 ident: ref_35 article-title: Detection of distant metastases in esophageal cancer with (18)F-FDG PET publication-title: J. Nucl. Med. contributor: fullname: Heeren – volume: 243 start-page: 472 year: 2006 ident: ref_43 article-title: Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer publication-title: Ann. Surg. doi: 10.1097/01.sla.0000208430.07050.61 contributor: fullname: Levine – volume: 37 start-page: 774 year: 2011 ident: ref_8 article-title: The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma publication-title: Eur. J. Surg. Oncol. doi: 10.1016/j.ejso.2011.06.002 contributor: fullname: Blom – volume: 21 start-page: 670 year: 1980 ident: ref_23 article-title: A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection publication-title: J. Nucl. Med. contributor: fullname: Som – volume: 34 start-page: 941 year: 2014 ident: ref_64 article-title: Abdominal and pelvic complications of nonoperative oncologic therapy publication-title: Radiographics doi: 10.1148/rg.344140082 contributor: fullname: Viswanathan – volume: 190 start-page: 562 year: 2000 ident: ref_4 article-title: Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study publication-title: J. Am. Coll. Surg. doi: 10.1016/S1072-7515(00)00238-6 contributor: fullname: Daly – volume: 40 start-page: 294 year: 2010 ident: ref_24 article-title: Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy publication-title: Semin. Nucl. Med. doi: 10.1053/j.semnuclmed.2010.02.002 contributor: fullname: Liu – volume: 165 start-page: 79 year: 1995 ident: ref_52 article-title: High-dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis publication-title: Am. J. Roentgenol. doi: 10.2214/ajr.165.1.7785638 contributor: fullname: Yamasaki – volume: 25 start-page: 195 year: 2011 ident: ref_55 article-title: Mechanisms of hepatic fibrogenesis publication-title: Best. Pract. Res. Clin. Gastroenterol. doi: 10.1016/j.bpg.2011.02.005 contributor: fullname: Lee – volume: 45 start-page: 1742 year: 2018 ident: ref_11 article-title: Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT publication-title: Eur. J. Nucl. Med. Mol. Imaging doi: 10.1007/s00259-018-4011-6 contributor: fullname: Goense – volume: 16 start-page: 75 year: 2013 ident: ref_47 article-title: Imaging patterns of liver uptakes on PET scan: Pearls and pitfalls publication-title: Nucl. Med. Rev. Cent. East. Eur. doi: 10.5603/NMR.2013.0039 contributor: fullname: Luk – volume: 7 start-page: 189 year: 2007 ident: ref_13 article-title: PET/CT and hepatic radiation injury in esophageal cancer patients publication-title: Cancer Imaging doi: 10.1102/1470-7330.2007.0027 contributor: fullname: Iyer – volume: 31 start-page: 1237 year: 1995 ident: ref_18 article-title: Hepatic toxicity resulting from cancer treatment publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/0360-3016(94)00418-K contributor: fullname: Lawrence – volume: 15 start-page: 1089 year: 1995 ident: ref_62 article-title: Straight border sign of the liver: Spectrum of CT appearances and causes publication-title: Radiographics doi: 10.1148/radiographics.15.5.7501852 contributor: fullname: Itai – volume: 117 start-page: 250 year: 2017 ident: ref_46 article-title: Hepatic radiation injury mimicking metastasis in distal esophageal cancer publication-title: Acta Chir. Belg. doi: 10.1080/00015458.2016.1248120 contributor: fullname: Demey – volume: 11 start-page: 264 year: 1987 ident: ref_60 article-title: CT and MR imaging of radiation hepatitis publication-title: J. Comput. Assist. Tomogr. doi: 10.1097/00004728-198703000-00013 contributor: fullname: Unger – volume: 109 start-page: 125 year: 2007 ident: ref_38 article-title: Detection of interval distant metastases: Clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy publication-title: Cancer doi: 10.1002/cncr.22397 contributor: fullname: Bruzzi – volume: 10 start-page: 240 year: 1963 ident: ref_19 article-title: Hepatic Injury Following Irradiation—A Morphologic Study publication-title: Tokushima J. Exp. Med. contributor: fullname: Ogata – volume: 187 start-page: 1204 year: 2006 ident: ref_61 article-title: Spectrum of imaging findings in the abdomen after radiotherapy publication-title: Am. J. Roentgenol. doi: 10.2214/AJR.05.0941 contributor: fullname: Kwek – volume: 349 start-page: 2241 year: 2003 ident: ref_54 article-title: Esophageal cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra035010 contributor: fullname: Enzinger – volume: 13 start-page: 361 year: 2002 ident: ref_39 article-title: Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer publication-title: Ann. Oncol. doi: 10.1093/annonc/mdf081 contributor: fullname: Flamen – volume: 381 start-page: 400 year: 2013 ident: ref_1 article-title: Oesophageal carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(12)60643-6 contributor: fullname: Pennathur – volume: 5 start-page: 52 year: 2021 ident: ref_63 article-title: Advances in liver US, CT, and MRI: Moving toward the future publication-title: Eur. Radiol. Exp. doi: 10.1186/s41747-021-00250-0 contributor: fullname: Vernuccio – volume: 14 start-page: 188 year: 2019 ident: ref_65 article-title: Evaluation of acute esophageal radiation-induced damage using magnetic resonance imaging: A feasibility study in mice publication-title: Radiat. Oncol. doi: 10.1186/s13014-019-1396-8 contributor: fullname: Jelvehgaran – volume: 39 start-page: 862 year: 2014 ident: ref_10 article-title: Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer publication-title: Clin. Nucl. Med. doi: 10.1097/RLU.0000000000000517 contributor: fullname: Stiekema – volume: 21 start-page: 256 year: 2011 ident: ref_58 article-title: Hepatic radiation toxicity: Avoidance and amelioration publication-title: Semin. Radiat. Oncol. doi: 10.1016/j.semradonc.2011.05.003 contributor: fullname: Guha – volume: 28 start-page: 4714 year: 2010 ident: ref_6 article-title: Outcomes of patients with esophageal cancer staged with [18F]fluorodeoxyglucose positron emission tomography (FDG-PET): Can postchemoradiotherapy FDG-PET predict the utility of resection? publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2010.30.7702 contributor: fullname: Monjazeb – volume: 26 start-page: 128 year: 1997 ident: ref_71 article-title: Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: Activation of hepatic stellate cells as an early event publication-title: Hepatology doi: 10.1002/hep.510260117 contributor: fullname: Sempoux – volume: 22 start-page: 900 year: 2004 ident: ref_56 article-title: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2004.07.122 contributor: fullname: Wieder – volume: 27 start-page: 1635 year: 2007 ident: ref_9 article-title: PET/CT of esophageal cancer: Its role in clinical management publication-title: Radiographics doi: 10.1148/rg.276065742 contributor: fullname: Bruzzi – volume: 48 start-page: 597 year: 1966 ident: ref_15 article-title: The human liver after radiation injury. A form of veno-occlusive disease publication-title: Am. J. Pathol. contributor: fullname: Reed – volume: 13 start-page: 851 year: 2007 ident: ref_20 article-title: Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-2459 contributor: fullname: Chou – volume: 19 start-page: 3058 year: 2001 ident: ref_41 article-title: Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2001.19.12.3058 contributor: fullname: Weber – volume: 17 start-page: 743 year: 2007 ident: ref_70 article-title: MR imaging of therapy-induced changes of bone marrow publication-title: Eur. Radiol. doi: 10.1007/s00330-006-0404-1 contributor: fullname: Henning – volume: 40 start-page: 560 year: 2016 ident: ref_12 article-title: Radiation-Induced Liver Injury Mimicking Metastatic Disease in a Patient With Esophageal Cancer: Correlation of Positron Emission Tomography/Computed Tomography With Magnetic Resonance Imaging and Literature Review publication-title: J. Comput. Assist. Tomogr. doi: 10.1097/RCT.0000000000000406 contributor: fullname: Rabe – volume: 39 start-page: 963 year: 2014 ident: ref_22 article-title: Radiation-induced liver disease as a mimic of liver metastases at serial PET/CT during neoadjuvant chemoradiation of distal esophageal cancer publication-title: Abdom. Imaging doi: 10.1007/s00261-014-0125-x contributor: fullname: Grant – volume: 49 start-page: 1374 year: 2013 ident: ref_34 article-title: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2012.12.027 contributor: fullname: Ferlay – volume: 14 start-page: 106 year: 2020 ident: ref_48 article-title: Phantom simulation of liver metastasis on a positron emission tomography with computed tomography scan after neoadjuvant chemoradiotherapy for distal esophageal cancer: A case report publication-title: J. Med. Case Rep. doi: 10.1186/s13256-020-02391-z contributor: fullname: Shai |
SSID | ssj0000331767 |
Score | 2.3637824 |
SecondaryResourceType | review_article |
Snippet | In patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy (nCRT), subsequent restaging with F-18-fluorodeoxyglucose (18F-FDG) positron... FDG PET-CT scans are critical in detecting metastases during neoadjuvant chemoradiotherapy for esophageal cancer, particularly for potential liver involvement.... Simple SummaryFDG PET-CT scans are critical in detecting metastases during neoadjuvant chemoradiotherapy for esophageal cancer, particularly for potential... |
SourceID | doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 948 |
SubjectTerms | Abdomen Avidity Biopsy Cancer therapies Chemoradiotherapy Chemotherapy Computed tomography CT imaging Development and progression Disease Esophageal cancer Esophageal carcinoma Esophagus F-18-fluorodeoxyglucose (18F-FDG) false liver metastasis Glucose Liver Liver cancer Liver diseases Lymphatic system Magnetic resonance imaging Medical imaging Metabolism Metastases Metastasis neoadjuvant chemoradiotherapy (nCRT) Patients PET imaging Physiology Positron emission tomography positron emission tomography–computed tomography (PET-CT) Radiation Radiation therapy radiation-induced liver disease (RILD) radiation-induced liver injury (RILI) Radiotherapy Review Surgery Tomography Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVQFxUbBC2PQKmMhASbaJI4fmRZqhlViIGRGKTuIr8CI7UJmqRI3fERfAWfxZdwr5MZJbBgw9b2JL4P2-dmrs8l5KXCjEXDszjhmsUQb8CaE5WKjeUcYjeuJMP7zsv34uJT_vaSX45KfWFOWE8P3Ctu5r3KrQe_LDKTM8-MyyqAzDyVFYQ-oodGKR8FU2EPZnAuCtlz-TCI62cWlbhtU4GEJ1jtZ3QMBbb-v_fk0aE0TZgcnUCL--TeAB3pWT_lB-SOr4_I4XL4c_yY_FyAK3n6DjMt6NJ3GoBfu2mpuaUrTM3aNjWdg1nx-xhdN9cDWfVsKOzgRm30IwhCQ_1wipQC4CduM9zVuqWAc-kcyx_AXgQTOg8y__r-Y9V0mHsETR--hRszn-Ghq01X6aurljYVXe-y2h-S9WK-Pr-Ih1IMsQV1dXEhXeEcRK7O6dQokYMDgopzYQtbpF7AoWa0ZZZbJq0DFJMYJb0QEF9KaTx7RA7qpvZPCM1ShtUoPARmKi9UooXUma4SrmxRWZ1H5PXOMOXXnnCjhEAFbVj-YcOIvEHD7YchU3ZoAP8pB_8p_-U_EXmFZi9xPYNtrR6uJcBskRmrPJMgLYN9HV53MhkJBrPT7p3jlMM-0JZZwXmAaGlEXuy78ZeY21b75iaMEULlTPCIPO79bC8SA_AAek4ioiYeOJF52lNvvgSWcOQJQ7z89H9o6Rm5mwGaC3f5xQk56LY3_jmgsc6choX3G9jVNvM priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELZKKyEuiH8CBRkJCS5Rfhw7zgm11a5WiC0rWKTeIv-lrFSSskmReuMheAoeiydhJussG5C42s6uxzMez9gz3xDyUmLEouZpGHPFQvA3YM-JSobacA6-G5c5w3zn-amYfcrenvGzPTIbcmEwrHLQib2ito3BO_IoLTjvD7skUhpvAUwXvbn8GmL9KHxn9cU0bpCDNMnwwfbgeHK6-LC9b4kZfCzyDboPA08_Mris6zYRCIGC9X92DqYev_9fLb1zTI1DKHfOpOkdctsbk_Row_27ZM_V98jNuX8uv09-TkG4HH2HsRd07joFpmC7aqm-pgsM1lo3NZ0Ao_HGjC6bLx6-OvKlHuxOG_0IhNC-ojhFkAGQHLvy2VvXFCxfOsGCCKCdYEInPc2_vv9YNB1GI0HT-299Ds05_Ohi1VXq4qKlTUWXQ5z7A7KcTpYns9AXZwgNLFcXFrktrAVf1lqVaCkyEElY4kyYwhSJE3DMaWWY4YblxoJdE2uZOyHA48xz7dhDsl83tXtMaJowrE_hwFWTWSFjJXKVqirm0hSVUVlAXg-MKS83EBwluC7Iw_IvHgbkGBm3HYbY2X1Dsz4v_VYsnZOZcaDpilRnzDFt0wqcMJ7kFTjTQgXkFbK9xB2OcqZ8ogLMFrGyyqMcqGWg6eHvDkcjgWFm3D0ITuk1Q1v-keOAvNh245cY7Va75qofI4TMmOABebSRsy1JDMwJWOc4IHIkgSOaxz316nOPG47IYWhBP_n_vJ6SWylYbn3evjgk-936yj0Dy6vTz_2m-g2RYTPd priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals (Open Access) dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgSIgXxJ2MgYyEBC9hiW9xHhAaU6sJUahEJ-0tsh1nq1QS1mSI_iN-Jue4aWlgD7zazuVcfHy-5FwIeaUxYtFKFifS8BjwBuw5VenYOikBu0mdccx3nnxWJ6fi45k8-9MOqGdgey20w35Sp8vF25-Xq_ew4d8h4gTIfuiQP8s2VVjLROib5BYTXKC6T3pfP5hlDkdl6CjLkozFSuViXernunsMTqlQzP9fk71zZg3jKXcOqPE9crf3LOnRWhXukxu-fkBuT_p_5w_JrzFQ7OknDMSgE98Z8AvbeUvtik4xcmvZ1HQEUsfPZ3TWfOtrWR_2fR_KnTH6FQihob04xYoDoEblvE_lWlFwg-kIuyOAqYIXOg40x9Omw8AkGPjyI6TTnMMtp_OuMotFS5uKzjYh74_IbDyaHZ_EfZ-G2AGzujjPyrwsAdaWpUmtVgK0E5gtlMtdnnoFJ541jjvpeOZKcHESqzOvFIDPLLOePyZ7dVP7p4SylGOrCg-oTYtcJ0ZlhpkqkdrllTMiIm82Yim-r6txFIBiUILFXxKMyAcU23YZltEOA83yvOh3ZeG9Fs6D0cuZFdxzW7IK8JhMswpwtTIReY1CL1D9QLLO9DkL8LZYNqs4yoBaDkYfHncwWAnicsPpjdoUGx0vWC5l8N_SiLzcTuOVGPhW--YqrFFKC65kRJ6stWxLEgfPAvicREQP9G9A83Cmnl-EEuJYRAyd6f3_ePAzcoeBJxfy-NUB2euWV_45eGKdfRF22G9NoTTR priority: 102 providerName: Scholars Portal |
Title | False Liver Metastasis by Positron Emission Tomography/Computed Tomography Scan after Chemoradiotherapy for Esophageal Cancer-Potential Overstaged Pitfalls of Treatment |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38473310 https://www.proquest.com/docview/2955431751/abstract/ https://search.proquest.com/docview/2956684365 https://pubmed.ncbi.nlm.nih.gov/PMC10931232 https://doaj.org/article/ee84ce70392b43e3bd2f428517f4026a |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3bbtMw1NqGhHhB3AkblZGQ4CVrE8eXPG5Vy4ToqKBIfYtsxxmV2mRqs0l74yP4Cj6LL-EcN6kaeOMlD7aT-Pjck3Mh5K3CiEXD43DANQvB3wCeE4UKjeUcfDeuJMN858mluPiWfJzz-QERbS6MD9q3ZnFaLlen5eK7j628Xtl-GyfWn06GWAIJTYH-ITmUjO356F7-MtCJQm7r-DDw6fsWD3C9iQQWO8FOP3sqyFfq_1ce7ymkbrDknvYZPyIPG7ORnm2395gcuPIJuT9pfow_Jb_GQEaOfsIoCzpxtQajb7PYUHNHpxiWta5KOgKU4rcxOqtWTaHqftPUId8bo18BEOp7h1MsJwA0ki-aPK07CjYuHWHrA5BDsKGhh_n3j5_Tqsa4Ixj6fOuzZa7godNFXejlckOrgs7aiPZnZDYezYYXYdOGIbRwXHWYyjzNc_Ba81xHRokEiA-OOBE2tWnkBCg0oy2z3DJpc7BgBkZJJwT4llIax56To7Iq3UtC44hhJwoHTplKUjXQQupYFwOubFpYnQTkfYuY7HpbbCMDJwVxmP2Fw4CcI-J2y7BKth-o1ldZQyuZcyqxDmRaGpuEOWbyuAB3i0eyALdZ6IC8Q7RnyMuAW6ublATYLVbFys4kQMtApsPrTjorAWG2O90STtbIgE0Wp5x78ywKyJvdNN6JcW2lq278GiFUwgQPyIstne1AYmA4wDkPAqI6FNiBuTsDDOMrhLcM8ur_bz0mD2Kw33z2vjghR_X6xr0G-6s2PXLvfHQ5_dLz3y_g-mEewXWSqJ5nxD-Prjqq |
link.rule.ids | 230,315,733,786,790,870,891,2115,2236,21416,24346,27957,27958,33779,33780,43840,53827,53829,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELegk4AXxH8CA4yEBC9Rkzh2nCe0Ta0KtKWCIO0tcmxnVNqSrcmQ9saH4FPwsfgk3KVuaUDi1XYSn-98vnPufkfIK4kRiwWP_IAr5oO_AXtOlNIvNOfgu3GZMMx3ns3F5Ev8_pgfuwu3xoVVbnRip6hNrfGOfBilnHeHXfj2_MLHqlH4d9WV0LhO9mIGrsqA7B2O5otP21uWgMEjIllj-jDw74caF3PVhAKBT7Dqz85x1KH2_6ubdw6nfuDkzkk0vkNuOxOSHqx5fpdcs9U9cmPmfpLfJz_HIFKWTjHigs5sq8AAbJYNLa7oAkO0VnVFR8BevCejWX3mQKuHrsCD2Wmjn4EQ2tURpwgtAPJili5n64qCvUtHWAYBdBJM6Kij-df3H4u6xRgkaPr4rcucOYGXLpZtqU5PG1qXNNtEtz8g2XiUHU18V5LB17BcrZ8mJjUGPFhjVFhIEYMgwhLHQqc6Da2Aw61QmmmuWaINWDNBIRMrBPiZSVJY9pAMqrqyjwmNQoZVKSw4aDJOZaBEoiJVBlzqtNQq9sibDWPy8zXwRg4OC_Iw_4uHHjlExm2HIWJ211CvTnK3AXNrZawt6Lc0KmJmWWGiElwvHiYluNBCeeQ1sj3HfQ281cqlJ8BsESErP0iAWgb6HT633xsJDNP97o3g5E4fNPkf6fXIy203PokxbpWtL7sxQsiYCe6RR2s525IEwo3FNQOPyJ4E9mju91TLrx1aOOKFod385P_zekFuTrLZNJ--m394Sm5FYLt1mftinwza1aV9BrZXWzx3G-w37eYzEA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3bbtMw1IJNmnhB3Bc2wEhI8BI1ieNLntA2Wg1YSwVF2ltkO86oNJKtyZD2xkfwFXwWX8I5qVsakHi1ncTH5-6cCyEvFEYsGp6EEdcsBH8DeE6UKjSWc_DduJIM853HE3H8OX13yk99_FPjwypXMrET1EVt8Y58kGScd8ouHpQ-LGL6ZvT64jLEDlL4p9W307hJtmUqOFD49uFwMv24vnGJGDwu5LK-DwNff2DxYBdNLLAICnYA2lBNXQX_f-X0hqLqB1FuaKXRHXLbm5P0YIn_u-SGq-6RnbH_YX6f_BwBeTl6gtEXdOxaDcZgM2-ouaZTDNda1BUdAqrxzozO6q--gPXAN3soNsboJwCEdj3FKZYZANop5j5_65qC7UuH2BIB5BNs6KiD-df3H9O6xXgkGPrwrcuiOYOXTudtqc_PG1qXdLaKdH9AZqPh7Og49O0ZQgvH1YaZLLKiAG-2KHRslEiBKOGIU2Ezm8VOgKIz2jLLLZO2AMsmMko6IcDnlNI49pBsVXXldglNYoYdKhw4ayrNVKSF1IkuI65sVlqdBuTVCjH5xbIIRw7OC-Iw_wuHATlExK2XYfXsbqBenOWeGXPnVGodyLosMSlzzBRJCW4Yj2UJ7rTQAXmJaM-RxwG3VvtUBdgtVsvKDyRAy0DWw-f2eysBYbY_vSKc3MuGJv9DyQF5vp7GJzHerXL1VbdGCJUywQPyaElna5AYGBRwzlFAVI8CezD3Z6r5l65yONYOQxv68f_39YzsAG_lJ28n7_fIrQTMuC6JX-yTrXZx5Z6AGdaap56_fgM6XzdN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=False+Liver+Metastasis+by+Positron+Emission+Tomography%2FComputed+Tomography+Scan+after+Chemoradiotherapy+for+Esophageal+Cancer-Potential+Overstaged+Pitfalls+of+Treatment&rft.jtitle=Cancers&rft.au=Shai%2C+Sen-Ei&rft.au=Lai%2C+Yi-Ling&rft.au=Chang%2C+Chen-I&rft.au=Hsieh%2C+Chi-Wei&rft.date=2024-02-26&rft.issn=2072-6694&rft.eissn=2072-6694&rft.volume=16&rft.issue=5&rft_id=info:doi/10.3390%2Fcancers16050948&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon |